{"SPADE_UN_15845": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15845", "Peptide Name": "Magainin-2 [G3,18K; K4,14Dap; F5W; A15K; E19K; M21Nle]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GIKXWLHSAKKFGXKFVKKIXNS", "Sequence Length": 23, "UniProt Entry": ["http://www.uniprot.org/uniprot/P11006"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:PANC-1 (EC50=14.7±0.6 µM(pH=7.4))", "Hemolytic Activity": "Human kidney-derived GM cells:EC50=25.9±0.6 µM(pH=6); EC50=50.3±0.9 µM(pH=7.4)", "Cytotoxicity": "HEK293:EC50=27.2±3.1 µM(pH=7.4)", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C111H172N30O21", "Mass": 298536, "PI": 11.5, "Net Charge": 7, "Hydrophobicity": -0.391, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues", "Pubmed ID": "31161686", "Reference": "Chembiochem. 2019 Aug 16;20(16)2109-2117.", "Author": "Tanishiki N, Yano Y, Matsuzaki K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31161686"}], "Frequent Amino Acids": "KXF", "Absent Amino Acids": "CDEMOPQRTUY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 12, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15846", "Similarity": 1.0, "Sequence": "GIKWLHSAKFGKFVKINS"}, {"SPADE_ID": "SPADE_UN_15847", "Similarity": 1.0, "Sequence": "GIKWLHSAFGKFVINS"}, {"SPADE_ID": "SPADE_UN_15844", "Similarity": 0.9, "Sequence": "GIKKWLHSAKKFGKKFVKKINS"}]}}}